Mounjaro Articles
In-depth, evidence-based articles about tirzepatide. Written for patients and caregivers, sourced from clinical trials and FDA prescribing information.
-
Mechanism of Action
How Tirzepatide Works: The Dual GIP/GLP-1 Mechanism Behind Mounjaro
Tirzepatide is the first FDA-approved dual GIP and GLP-1 receptor agonist. What that means, why it differs from semaglutide and other GLP-1 drugs, and what the SURPASS trials show about its clinical impact.
-
Dosing Guide
Mounjaro Dosing Schedule: Complete Titration Guide from 2.5 mg to 15 mg
The full titration schedule, what to expect at each dose level, how to handle missed doses, and practical injection tips. Based on FDA-approved prescribing information and SURPASS trial protocols.
-
Side Effects
Managing Mounjaro Side Effects: What Works and When to Call Your Doctor
Practical strategies for the most common side effects, including nausea, diarrhea, and constipation. Rates from clinical trials, warning signs for serious adverse events, and when to contact your prescriber.
-
Weight Loss
Mounjaro Weight Loss: Realistic Expectations Based on Clinical Trial Data
What the SURPASS and SURMOUNT trials actually show about weight loss on tirzepatide. Average results by dose, timelines, individual variation, body composition, and what happens when you stop.
-
Cost & Access
Mounjaro Cost and Insurance Coverage in 2026: What You Need to Know
Current pricing, commercial insurance coverage, Medicare and Medicaid, the Eli Lilly savings card, patient assistance programs, and strategies for reducing out-of-pocket costs.
-
Diet & Nutrition
What to Eat on Mounjaro: A Practical Diet Guide
Evidence-based dietary guidance for people on tirzepatide. Protein targets, meal structure, foods to avoid, hydration, micronutrient considerations, and building sustainable eating habits.